AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,361,869 | -30.9% | 55,025 | -21.0% | 0.00% | -100.0% |
| Q2 2023 | $1,971,639 | +235.7% | 69,620 | +172.3% | 0.00% | – |
| Q1 2023 | $587,366 | -29.6% | 25,571 | -13.9% | 0.00% | – |
| Q4 2022 | $834,425 | -25.4% | 29,716 | -41.1% | 0.00% | – |
| Q2 2022 | $1,119,000 | -28.0% | 50,479 | -5.5% | 0.00% | – |
| Q1 2022 | $1,555,000 | -82.7% | 53,438 | -80.4% | 0.00% | -100.0% |
| Q4 2021 | $8,969,000 | -26.8% | 272,899 | +2.7% | 0.00% | -25.0% |
| Q3 2021 | $12,259,000 | -15.1% | 265,645 | +1.4% | 0.00% | -33.3% |
| Q2 2021 | $14,432,000 | +39.2% | 261,875 | +30.4% | 0.01% | 0.0% |
| Q1 2021 | $10,370,000 | -20.0% | 200,813 | -32.9% | 0.01% | 0.0% |
| Q4 2020 | $12,959,000 | +111.5% | 299,067 | +70.8% | 0.01% | +100.0% |
| Q3 2020 | $6,128,000 | -26.6% | 175,056 | +12.1% | 0.00% | -40.0% |
| Q2 2020 | $8,349,000 | +1362.2% | 156,117 | +869.7% | 0.01% | – |
| Q1 2020 | $571,000 | -70.4% | 16,100 | -60.2% | 0.00% | -100.0% |
| Q4 2019 | $1,932,000 | +355.7% | 40,458 | +209.5% | 0.00% | +200.0% |
| Q3 2019 | $424,000 | +12.8% | 13,071 | +134.3% | 0.00% | 0.0% |
| Q1 2019 | $376,000 | -77.2% | 5,578 | -74.0% | 0.00% | -75.0% |
| Q3 2018 | $1,652,000 | +80.7% | 21,413 | +97.3% | 0.00% | +100.0% |
| Q2 2018 | $914,000 | +294.0% | 10,852 | +141.2% | 0.00% | +100.0% |
| Q2 2017 | $232,000 | -88.3% | 4,500 | -88.0% | 0.00% | -90.0% |
| Q3 2016 | $1,982,000 | +458.3% | 37,527 | +329.1% | 0.01% | +400.0% |
| Q1 2016 | $355,000 | +19.9% | 8,746 | +228.7% | 0.00% | 0.0% |
| Q2 2015 | $296,000 | -75.3% | 2,661 | -75.1% | 0.00% | -77.8% |
| Q4 2014 | $1,198,000 | +87.8% | 10,692 | -23.3% | 0.01% | +12.5% |
| Q2 2014 | $638,000 | – | 13,933 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |